Condition
Biliopancreatic Diversion
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Unknown2
Clinical Trials (2)
Showing 2 of 2 trials
NCT01046994Phase 3Unknown
Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
NCT00996294Not ApplicableUnknown
Surgical Treatment of Type 2 Diabetes Mellitus in <35 Body Mass Index (BMI)
Showing all 2 trials